12-80377173-A-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001378609.3(OTOGL):c.6832A>G(p.Arg2278Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,609,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001378609.3 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 84BInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001378609.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OTOGL | NM_001378609.3 | MANE Select | c.6832A>G | p.Arg2278Gly | missense | Exon 58 of 59 | NP_001365538.2 | ||
| OTOGL | NM_001378610.3 | c.6832A>G | p.Arg2278Gly | missense | Exon 61 of 62 | NP_001365539.2 | |||
| OTOGL | NM_173591.7 | c.6832A>G | p.Arg2278Gly | missense | Exon 58 of 59 | NP_775862.4 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OTOGL | ENST00000547103.7 | TSL:5 MANE Select | c.6832A>G | p.Arg2278Gly | missense | Exon 58 of 59 | ENSP00000447211.2 | ||
| OTOGL | ENST00000646859.1 | c.6697A>G | p.Arg2233Gly | missense | Exon 62 of 63 | ENSP00000496036.1 | |||
| OTOGL | ENST00000298820.7 | TSL:5 | c.2026A>G | p.Arg676Gly | missense | Exon 17 of 18 | ENSP00000298820.3 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152142Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000283 AC: 7AN: 247014 AF XY: 0.0000224 show subpopulations
GnomAD4 exome AF: 0.00000686 AC: 10AN: 1457702Hom.: 0 Cov.: 29 AF XY: 0.00000552 AC XY: 4AN XY: 725198 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74444 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Arg2269Gly variant in OTOGL has not been previously reported in individual s with hearing loss, but has been identified in 4/10336 of African chromosomes b y the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs372725776). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational predi ction tools and conservation analysis do not provide strong support for or again st an impact to the protein. In summary, the clinical significance of the p.Arg2 269Gly variant is uncertain.
not provided Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at